Related Experiment Video
Updated: Apr 28, 2026

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer
Published on: April 21, 2022
Narrative review: mucus plugging in chronic obstructive lung diseases and bronchiectasis
Charlotte Schou1, Tuuli Thomander2, Hanna Hisinger-Mölkänen3
1Department of Respiratory Diseases, Aalborg University Hospital, Aalborg, Denmark.
Mucus plugging is a significant marker in obstructive lung diseases, impacting prognosis. Standardizing CT scoring and developing targeted therapies are crucial for clinical integration and improved patient outcomes.
Area of Science:
- Pulmonary Medicine
- Radiology
- Medical Imaging
Background:
- Mucus plugging, defined as complete intraluminal occlusions, is frequently observed in high-resolution computed tomography (CT) scans of patients with obstructive lung diseases.
- It is increasingly recognized as a clinically significant finding with prognostic implications.
Purpose of the Study:
- To provide a narrative review on the pathophysiology, clinical consequences, and treatment of mucus plugging.
- To highlight the clinical relevance and prognostic value of mucus plugging in various obstructive airway diseases.
Main Methods:
- A comprehensive literature review was conducted.
- The review focused on studies detailing the pathophysiology, clinical impact, and therapeutic strategies for mucus plugging.
Main Results:
- Mucus plugging is associated with infections (e.g., Pseudomonas aeruginosa, non-tuberculosis mycobacteria) and exacerbations in bronchiectasis.
- In chronic obstructive pulmonary disease (COPD), mucus plugging correlates with increased airflow obstruction, poorer health status, higher exacerbation risk, and mortality.
- In asthma, mucus plugging is linked to severe disease and adverse outcomes.
- Existing CT scoring systems for mucus plugs are heterogeneous, limiting comparability.
Conclusions:
- Mucus plugs serve as measurable markers of disease activity with prognostic relevance across obstructive airway diseases.
- Clinical adoption is hampered by non-standardized CT scoring and a lack of plug-targeted trials.
- Emerging treatments, such as biologics (e.g., dupilumab for asthma) and azithromycin for infection prevention, show promise.
- Standardization and validation of CT-based scoring systems are essential for clinical integration.
More Related Videos
05:19Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension
Published on: September 1, 2023
06:57The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
Published on: May 8, 2017
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation